文献速递产科母胎医学

母体SARS-CoV-2感染后胎盘抗病毒先天免疫基因表达降低

Diminished antiviral innate immune gene expression in the placenta following a maternal SARS-CoV-2 infection.
PubMed 文献 · Am J Obstet Gynecol · 2022-09-17

病例对照研究纳入140例COVID-19孕妇和24例无COVID-19孕妇的胎盘组织,检测6种抗病毒先天免疫介质基因表达。活动期或恢复期COVID-19孕妇的绒毛膜绒毛和绒毛膜羊膜中IFNB、IFIT1、MXA、IL6、IL1B基因表达低于对照,校正分娩状态后仍显著。胎盘基因表达与诊断孕周、诊断至分娩间隔、孕前BMI、疾病严重程度或胎盘病理无明显相关。

要点

  • COVID-19孕妇胎盘IFNB、IFIT1、MXA、IL6、IL1B基因表达低于无COVID-19对照。
  • 仅5例COVID-19孕妇胎盘组织检出SARS-CoV-2 RNA,其中1例合胞体滋养细胞表达核衣壳和刺突蛋白。
  • 胎盘先天免疫基因表达与诊断孕周、诊断至分娩间隔、孕前BMI、疾病严重程度及胎盘病理无明显相关。

核心结论

  • 母体SARS-CoV-2感染与绒毛膜绒毛和绒毛膜羊膜中胎盘先天免疫反应受损相关,该损伤与COVID-19诊断孕周、诊断至分娩间隔、母体肥胖、疾病严重程度或胎盘病理无相关性。

研究设计与样本

  • 病例对照研究,纳入有COVID-19孕妇140例和无COVID-19孕妇24例的胎盘组织(绒毛膜绒毛组织和绒毛膜羊膜)。
  • 采用实时定量聚合酶链反应和免疫组织化学检测,并评估胎盘组织病理学,收集临床资料。
  • 使用Fisher精确检验、Pearson相关和线性回归模型比较分娩时活动期COVID-19(诊断后<10天)与恢复期COVID-19(诊断后>10天)患者之间的比例和连续数据。
  • 二次回归模型校正分娩状态作为协变量,评估胎盘先天免疫基因表达与其他变量之间的潜在相关性。

主要发现

  • 5例COVID-19孕妇胎盘组织检出SARS-CoV-2病毒RNA,无对照检出(0/24,0%)。
  • 5例胎盘组织检出SARS-CoV-2病毒RNA的病例中,仅1例确认合胞体滋养细胞表达SARS-CoV-2核衣壳和刺突蛋白。
  • 活动期或恢复期COVID-19孕妇的绒毛膜绒毛和绒毛膜羊膜中5种关键先天免疫介质(IFNB、IFIT1、MXA、IL6、IL1B)基因表达低于对照,校正分娩状态后仍显著。
  • 胎盘基因表达与诊断时孕周、COVID-19诊断至分娩时间间隔、孕前体重指数、COVID-19疾病严重程度或胎盘病理等其他研究变量之间相关性极小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COVID-19 is caused by the SARS-CoV-2 virus and is associated with critical illness requiring hospitalization, maternal mortality, stillbirth, and preterm birth. SARS-CoV-2 has been shown to induce placental pathology. However, substantial gaps exist in our understanding of the pathophysiology of COVID-19 disease in pregnancy and the long-term impact of SARS-CoV-2 on the placenta and fetus. To what extent a SARS-CoV-2 infection of the placenta alters the placental antiviral innate immune response is not well understood. A dysregulated innate immune response in the setting of maternal COVID-19 disease may increase the risk of inflammatory tissue injury or placental compromise and may contribute to deleterious pregnancy outcomes. OBJECTIVE: We sought to determine the impact of a maternal SARS-CoV-2 infection on placental immune response by evaluating gene expression of a panel of 6 antiviral innate immune mediators that act as biomarkers of the antiviral and interferon cytokine response. Our hypothesis was that a SARS-CoV-2 infection during pregnancy would result in an up-regulated placental antiviral innate immune response. STUDY DESIGN: We performed a case-control study on placental tissues (chorionic villous tissues and chorioamniotic membrane) collected from pregnant patients with (N=140) and without (N=24) COVID-19 disease. We performed real-time quantitative polymerase chain reaction and immunohistochemistry, and the placental histopathology was evaluated. Clinical data were abstracted. Fisher exact test, Pearson correlations, and linear regression models were used to examine proportions and continuous data between patients with active (<10 days since diagnosis) vs recovered COVID-19 (>10 days since diagnosis) at the time of delivery. Secondary regression models adjusted for labor status as a covariate and evaluated potential correlation between placental innate immune gene expression and other variables. RESULTS: SARS-CoV-2 viral RNA was detected in placental tissues from 5 women with COVID-19 and from no controls (0/24, 0%). Only 1 of 5 cases with detectable SARS-CoV-2 viral RNA in placental tissues was confirmed to express SARS-CoV-2 nucleocapsid and spike proteins in syncytiotrophoblast cells. We detected a considerably lower gene expression of 5 critical innate immune mediators (IFNB, IFIT1, MXA, IL6, IL1B) in the chorionic villi and chorioamniotic membranes from women with active or recovered COVID-19 than controls, which remained significant after adjustment for labor status. There were minimal correlations between placental gene expression and other studied variables including gestational age at diagnosis, time interval between COVID-19 diagnosis and delivery, prepregnancy body mass index, COVID-19 disease severity, or placental pathology. CONCLUSION: A maternal SARS-CoV-2 infection was associated with an impaired placental innate immune response in chorionic villous tissues and chorioamniotic membranes that was not correlated with gestational age at COVID-19 diagnosis, time interval from COVID-19 diagnosis to delivery, maternal obesity, disease severity, or placental pathology.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Coler B, Wu TY, Carlson L, et al. Diminished antiviral innate immune gene expression in the placenta following a maternal SARS-CoV-2 infection. Am J Obstet Gynecol. 2022. PMID: 36126729. doi:10.1016/j.ajog.2022.09.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。